First Time Loading...

Mettler-Toledo International Inc
NYSE:MTD

Watchlist Manager
Mettler-Toledo International Inc Logo
Mettler-Toledo International Inc
NYSE:MTD
Watchlist
Price: 1 082.16 USD +0.21% Market Closed
Updated: Nov 29, 2023

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Mettler-Toledo International Inc

Revenue
3.9B USD
Cost of Revenue
-1.6B USD
Gross Profit
2.3B USD
Operating Expenses
-1.2B USD
Operating Income
1.2B USD
Other Expenses
-292.7m USD
Net Income
870m USD

Margins Comparison
Mettler-Toledo International Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Mettler-Toledo International Inc
NYSE:MTD
23.5B USD
59%
30%
22%
US
Thermo Fisher Scientific Inc
NYSE:TMO
188B USD
40%
17%
14%
US
Danaher Corp
NYSE:DHR
162B USD
59%
24%
20%
KR
Samsung Biologics Co Ltd
KRX:207940
51.6T KRW
50%
32%
24%
US
IQVIA Holdings Inc
NYSE:IQV
38.6B USD
35%
13%
7%
US
Agilent Technologies Inc
NYSE:A
36.5B USD
51%
20%
16%
CN
WuXi AppTec Co Ltd
SSE:603259
250B CNY
37%
24%
22%
CH
Lonza Group AG
SIX:LONN
25.3B CHF
39%
22%
20%
US
West Pharmaceutical Services Inc
NYSE:WST
26.1B USD
38%
24%
19%
CN
WuXi Biologics (Cayman) Inc
HKEX:2269
189B HKD
42%
27%
25%
IE
ICON PLC
NASDAQ:ICLR
21.9B USD
30%
12%
6%
Country US
Market Cap 23.5B USD
Gross Margin
59%
Operating Margin
30%
Net Margin
22%
Country US
Market Cap 188B USD
Gross Margin
40%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 162B USD
Gross Margin
59%
Operating Margin
24%
Net Margin
20%
Country KR
Market Cap 51.6T KRW
Gross Margin
50%
Operating Margin
32%
Net Margin
24%
Country US
Market Cap 38.6B USD
Gross Margin
35%
Operating Margin
13%
Net Margin
7%
Country US
Market Cap 36.5B USD
Gross Margin
51%
Operating Margin
20%
Net Margin
16%
Country CN
Market Cap 250B CNY
Gross Margin
37%
Operating Margin
24%
Net Margin
22%
Country CH
Market Cap 25.3B CHF
Gross Margin
39%
Operating Margin
22%
Net Margin
20%
Country US
Market Cap 26.1B USD
Gross Margin
38%
Operating Margin
24%
Net Margin
19%
Country CN
Market Cap 189B HKD
Gross Margin
42%
Operating Margin
27%
Net Margin
25%
Country IE
Market Cap 21.9B USD
Gross Margin
30%
Operating Margin
12%
Net Margin
6%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Mettler-Toledo International Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Mettler-Toledo International Inc
NYSE:MTD
23.5B USD
-922%
26%
53%
32%
US
Thermo Fisher Scientific Inc
NYSE:TMO
188B USD
14%
6%
9%
8%
US
Danaher Corp
NYSE:DHR
162B USD
12%
7%
9%
8%
KR
Samsung Biologics Co Ltd
KRX:207940
51.6T KRW
9%
5%
9%
7%
US
IQVIA Holdings Inc
NYSE:IQV
38.6B USD
20%
4%
10%
7%
US
Agilent Technologies Inc
NYSE:A
36.5B USD
21%
11%
16%
13%
CN
WuXi AppTec Co Ltd
SSE:603259
250B CNY
21%
15%
21%
16%
CH
Lonza Group AG
SIX:LONN
25.3B CHF
12%
7%
10%
8%
US
West Pharmaceutical Services Inc
NYSE:WST
26.1B USD
21%
16%
23%
23%
CN
WuXi Biologics (Cayman) Inc
HKEX:2269
189B HKD
12%
8%
11%
10%
IE
ICON PLC
NASDAQ:ICLR
21.9B USD
6%
3%
7%
5%
Country US
Market Cap 23.5B USD
ROE
-922%
ROA
26%
ROCE
53%
ROIC
32%
Country US
Market Cap 188B USD
ROE
14%
ROA
6%
ROCE
9%
ROIC
8%
Country US
Market Cap 162B USD
ROE
12%
ROA
7%
ROCE
9%
ROIC
8%
Country KR
Market Cap 51.6T KRW
ROE
9%
ROA
5%
ROCE
9%
ROIC
7%
Country US
Market Cap 38.6B USD
ROE
20%
ROA
4%
ROCE
10%
ROIC
7%
Country US
Market Cap 36.5B USD
ROE
21%
ROA
11%
ROCE
16%
ROIC
13%
Country CN
Market Cap 250B CNY
ROE
21%
ROA
15%
ROCE
21%
ROIC
16%
Country CH
Market Cap 25.3B CHF
ROE
12%
ROA
7%
ROCE
10%
ROIC
8%
Country US
Market Cap 26.1B USD
ROE
21%
ROA
16%
ROCE
23%
ROIC
23%
Country CN
Market Cap 189B HKD
ROE
12%
ROA
8%
ROCE
11%
ROIC
10%
Country IE
Market Cap 21.9B USD
ROE
6%
ROA
3%
ROCE
7%
ROIC
5%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More